Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Precursor B-Cell Lymphoblastic Leukemia-Lymphoma"" wg kryterium: Temat


Tytuł:
Reduced-dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B-cell acute lymphoblastic leukemia.
Autorzy:
Lu J; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Zhou H; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Zhou X; Department of Hematology, Wuxi People's Hospital Affiliated to Nanjing Medical University, WuXi, China.
Yang Y; Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Tong L; Yixing People's Hospital, The Affiliated Hospital of Jiangsu University, Yixing, China.
Miao M; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Yang X; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Chen S; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7062.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Bispecific*/adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Burkitt Lymphoma*/drug therapy
Humans ; Retrospective Studies ; Induction Chemotherapy
Czasopismo naukowe
Tytuł:
Importance of Rare Gene Alterations in the Prognosis of B-Cell Acute Lymphoblastic Leukemia
Autorzy:
Xiang L; Zhejiang Provincial People’s Hospital Bijie Hospital, Department of Science and Education, Bijie, China
Wang Y; Xinchang Hospital Affiliated to Wenzhou Medical University, Department of Thoracic Surgery, Xinchang, China
Pan W; Haiyan People’s Hospital, Department of Clinical Laboratory, Haiyan, China
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 49-50. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Burkitt Lymphoma*
Humans ; Prognosis
Czasopismo naukowe
Tytuł:
Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia.
Autorzy:
Bwanika HC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Leo IR; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Struyf N; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Talanti A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Aswad L; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Konnur A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Björklund AC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Huddinge, Sweden.
Heyman M; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Rassidakis G; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Erkers T; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Seashore-Ludlow B; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Jafari R; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Pokrovskaja Tamm K; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 4000. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Autophagy ; Cell Line ; Glucocorticoids/therapeutic use ; Cell Line, Tumor ; Apoptosis
Czasopismo naukowe
Tytuł:
CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.
Autorzy:
Gutierrez-Camino A; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Caron M; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.; Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.
Richer C; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Fuchs C; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Illarregi U; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
Poncelet L; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
St-Onge P; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Bataille AR; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Tremblay-Dauphinais P; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Lopez-Lopez E; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Pediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
Camos M; Hematology Laboratory, Sant Joan de Déu Research Institute, Esplugues de Llobregat, 08950 Barcelona, Spain.
Ramirez-Orellana M; Department of Pediatric Hematology and Oncology, Niño Jesús University Hospital, 28009 Madrid, Spain.
Astigarraga I; Pediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Pediatrics, Cruces University Hospital, 48903 Barakaldo, Spain.
Lécuyer É; Institut de Recherches Cliniques de Montréal (IRCM), Montreal, QC H2W 1R7, Canada.; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC H3C 3J7, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC H3A 0G4, Canada.
Bourque G; Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.
Martin-Guerrero I; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Pediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
Sinnett D; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.; Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, QC H3C 3J7, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 25; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
RNA, Circular*/genetics
Humans ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Tytuł:
Plasma-derived exosomal miR-326, a prognostic biomarker and novel candidate for treatment of drug resistant pediatric acute lymphoblastic leukemia.
Autorzy:
Saffari N; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Hezar jarib Street, Isfahan, 81746-73441, Iran.
Rahgozar S; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Hezar jarib Street, Isfahan, 81746-73441, Iran. .
Faraji E; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Hezar jarib Street, Isfahan, 81746-73441, Iran.
Sahin F; Department of Genetics and Bioengineering, Yeditepe University, Atasehir, 34755, Istanbul, Turkey.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 06; Vol. 14 (1), pp. 691. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
MicroRNAs*/genetics
Humans ; Child ; Prognosis ; Biomarkers
Czasopismo naukowe
Tytuł:
Constitutively active CaMKII Drives B lineage acute lymphoblastic leukemia/lymphoma in tp53 mutant zebrafish.
Autorzy:
Rothschild SC; Life Sciences, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Lai G; Pathology, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Tombes RM; Life Sciences, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Clements WK; Experimental Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2023 Dec 20; Vol. 19 (12), pp. e1011102. Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Child ; Animals ; Humans ; Zebrafish/genetics ; Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics ; Calcium
Czasopismo naukowe
Tytuł:
The effectiveness of blinatumomab in clearing measurable residual disease in pediatric B-cell acute lymphoblastic leukemia patients detected by next-generation sequencing.
Autorzy:
Gu M; Division of Hematology-Oncology, Children's Hospital of Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou, China.
Xia Y; Division of Hematology-Oncology, Children's Hospital of Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou, China.
Zhang J; Division of Hematology-Oncology, Children's Hospital of Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou, China.
Tang Y; Division of Hematology-Oncology, Children's Hospital of Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou, China.
Xu W; Division of Hematology-Oncology, Children's Hospital of Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou, China.
Song H; Division of Hematology-Oncology, Children's Hospital of Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou, China.
Xu X; Division of Hematology-Oncology, Children's Hospital of Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 21978-21984. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Antibodies, Bispecific*/therapeutic use
Burkitt Lymphoma*/drug therapy
Humans ; Child ; Retrospective Studies ; Neoplasm, Residual/drug therapy ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe
Tytuł:
Transcription factor 12-mediated self-feedback regulatory mechanism is required in DUX4 fusion leukaemia.
Autorzy:
Li Z; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Jiang M; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Wang J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Zhuo Z; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Zhang S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Tan Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.
Hu W; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.; Department of Geriatrics and Medical Center on Aging, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Zhang H; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.; Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Jinshan Hospital, Fudan University, Shanghai, P. R. China.
Meng G; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P. R. China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, First Affiliated Hospital of Xinjiang Medical University, Xinjiang, P. R. China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Dec; Vol. 13 (12), pp. e1514.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Leukemia, B-Cell*
Animals ; Humans ; Feedback ; Cell Line ; Carcinogenesis/genetics ; Mammals
Czasopismo naukowe
Tytuł:
Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction.
Autorzy:
Wolffhardt TM; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Ketzer F; Center for Molecular and Cellular Oncology, Yale School of Medicine, New Haven, CT 06510, USA.
Telese S; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Wirth T; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Ushmorov A; Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 17; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Myeloma*/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Humans ; Cell Line, Tumor ; Leukemia/metabolism ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr virus viremia after transplantation.
Autorzy:
Li S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Ge J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhou S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Zhu W; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Han Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Xue S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Wang Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Wu X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Oct; Vol. 13 (10), pp. e1459.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Chimeric Antigen*/genetics
Epstein-Barr Virus Infections*
Hematopoietic Stem Cell Transplantation*/adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Humans ; Cytomegalovirus ; Herpesvirus 4, Human ; Viremia ; Sialic Acid Binding Ig-like Lectin 2
Raport
Tytuł:
Amplification of the BCR::ABL1 Fusion Gene: A Rare Phenomenon in B-cell Acute Lymphoblastic Leukemia.
Autorzy:
Ray D; Postgraduate Institute of Medical Education and Research, Department of Hematopathology, Chandigarh, India.
Sharma P; Postgraduate Institute of Medical Education and Research, Department of Hematopathology, Chandigarh, India.
Jain A; Postgraduate Institute of Medical Education and Research, Department of Clinical Hematology and Medical Oncology, Chandigarh, India.
Sreedharanunni S; Postgraduate Institute of Medical Education and Research, Department of Hematopathology, Chandigarh, India.
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Aug 31; Vol. 40 (3), pp. 204-205.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Burkitt Lymphoma*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Humans
Czasopismo naukowe
Tytuł:
Isolated lacrimal gland enlargement as a presenting sign of relapse of B-cell acute lymphoblastic leukemia in an adult.
Autorzy:
Stevanovic M; Department of Ophthalmology, Ophthalmic Plastic Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
Yoon MK; Department of Ophthalmology, Ophthalmic Plastic Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło:
Digital journal of ophthalmology : DJO [Digit J Ophthalmol] 2023 Sep 30; Vol. 29 (3), pp. 73-76. Date of Electronic Publication: 2023 Sep 30 (Print Publication: 2023).
Typ publikacji:
Case Reports
MeSH Terms:
Lacrimal Apparatus*/diagnostic imaging
Lacrimal Apparatus*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Humans ; Adult ; Female ; Recurrence ; Philadelphia Chromosome
Raport
Tytuł:
RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Autorzy:
Sharma G; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Tran TM; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Bansal I; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Beg MS; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Bhardwaj R; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Bassi J; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Tan Y; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Jaiswal AK; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Tso C; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Jain A; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Singh J; Department of Laboratory Oncology, Dr B.R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Chattopadhyay P; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Singh A; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Chopra A; Department of Laboratory Oncology, Dr B.R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Bakhshi S; Department of Medical Oncology, Dr B.R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Casero D; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Rao DS; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Palanichamy JK; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Sep 05; Vol. 42 (1), pp. 231. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Animals ; Mice ; Core Binding Factor Alpha 2 Subunit ; Mice, Knockout ; Phosphatidylinositol 3-Kinases ; ETS Translocation Variant 6 Protein
Czasopismo naukowe
Tytuł:
Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases.
Autorzy:
Liu YJ; Sun Yat-sen University Cancer Center, Guangzhou, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangzhou, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangzhou, 510060, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Li XH; Sun Yat-sen University Cancer Center, Guangzhou, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangzhou, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangzhou, 510060, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Song YL; Sun Yat-sen University Cancer Center, Guangzhou, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangzhou, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangzhou, 510060, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Zhou YC; Sun Yat-sen University Cancer Center, Guangzhou, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangzhou, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangzhou, 510060, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Cai RZ; Sun Yat-sen University Cancer Center, Guangzhou, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangzhou, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangzhou, 510060, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Chi PD; Sun Yat-sen University Cancer Center, Guangzhou, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangzhou, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangzhou, 510060, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 May; Vol. 12 (10), pp. 11284-11292. Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/diagnosis
Hematologic Diseases*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*
Humans ; Follow-Up Studies ; Prognosis ; Acute Disease
Czasopismo naukowe
Tytuł:
IGFBP7 Fuels the Glycolytic Metabolism in B-Cell Precursor Acute Lymphoblastic Leukemia by Sustaining Activation of the IGF1R-Akt-GLUT1 Axis.
Autorzy:
Artico LL; Centro Infantil Boldrini, Campinas 13083-210, SP, Brazil.; Graduate Program in Genetics and Molecular Biology, Institute of Biology, University of Campinas, Campinas 13083-862, SP, Brazil.
Ruas JS; Centro Infantil Boldrini, Campinas 13083-210, SP, Brazil.
Teixeira Júnior JR; Centro Infantil Boldrini, Campinas 13083-210, SP, Brazil.; Graduate Program in Genetics and Molecular Biology, Institute of Biology, University of Campinas, Campinas 13083-862, SP, Brazil.
Migita NA; Centro Infantil Boldrini, Campinas 13083-210, SP, Brazil.
Seguchi G; Centro Infantil Boldrini, Campinas 13083-210, SP, Brazil.
Shi X; Department of Computer and Information Sciences, Temple University, Philadelphia, PA 19122, USA.
Brandalise SR; Centro Infantil Boldrini, Campinas 13083-210, SP, Brazil.
Castilho RF; Department of Pathology, School of Medical Sciences, University of Campinas, Campinas 13083-887, SP, Brazil.
Yunes JA; Centro Infantil Boldrini, Campinas 13083-210, SP, Brazil.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 02; Vol. 24 (11). Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Proto-Oncogene Proteins c-akt*/metabolism
Insulin-Like Growth Factor Binding Proteins*
Humans ; Cell Line, Tumor ; Cell Proliferation ; Glucose Transporter Type 1/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Receptor, IGF Type 1/metabolism
Czasopismo naukowe
Tytuł:
Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia.
Autorzy:
Panuciak K; Student Scientific Society, Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.
Nowicka E; Student Scientific Society, Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.
Mastalerczyk A; Student Scientific Society, Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.
Zawitkowska J; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Gębali 6, 20-093 Lublin, Poland.
Niedźwiecki M; Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Debinki 7, 80-211 Gdansk, Poland.
Lejman M; Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 15; Vol. 24 (10). Date of Electronic Publication: 2023 May 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Burkitt Lymphoma*
Humans ; Child ; Aneuploidy
Czasopismo naukowe
Tytuł:
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
Autorzy:
Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA. .
Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jorgensen J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Khouri I; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Kebriaei P; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Paul S; Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Dabaja B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Jacob J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
O'Brien S; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, USA.
Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2023 May 02; Vol. 16 (1), pp. 44. Date of Electronic Publication: 2023 May 02.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Bispecific*/adverse effects
Cardiovascular Diseases*/chemically induced
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Adult ; Humans ; Inotuzumab Ozogamicin/therapeutic use ; Methotrexate/therapeutic use ; Salvage Therapy/methods
Czasopismo naukowe
Tytuł:
Single-cell transcriptome analysis profiles the expression features of TMEM173 in BM cells of high-risk B-cell acute lymphoblastic leukemia.
Autorzy:
Cai Y; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, China.
Chen X; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, China.
Lu T; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, China.
Yu Z; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, China.
Hu S; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, China.
Liu J; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, China.
Zhou X; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, Shandong, 250021, China. .; Shandong Provincial Engineering Research Center of Lymphoma, Jinan, Shandong, 250021, China. .; Branch of National Clinical Research Center for Hematologic Diseases, Jinan, Shandong, 250021, China. .; National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, 251006, China. .
Wang X; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, China. .; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, Shandong, 250021, China. .; Shandong Provincial Engineering Research Center of Lymphoma, Jinan, Shandong, 250021, China. .; Branch of National Clinical Research Center for Hematologic Diseases, Jinan, Shandong, 250021, China. .; National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, 251006, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Apr 24; Vol. 23 (1), pp. 372. Date of Electronic Publication: 2023 Apr 24.
Typ publikacji:
Journal Article
MeSH Terms:
Leukocytes, Mononuclear*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Humans ; Single-Cell Gene Expression Analysis ; Killer Cells, Natural ; NF-kappa B/genetics ; RNA, Messenger/genetics ; Transcriptome ; Single-Cell Analysis
Czasopismo naukowe
Tytuł:
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy.
Autorzy:
Li W; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Ding L; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shi W; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Department of Hematology/Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Wan X; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yang X; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yang J; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wang T; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Song L; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wang X; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Ma Y; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Luo C; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Tang J; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Gu L; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Chen J; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Lu J; Department of Hematology/Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China. drlujun_.
Tang Y; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. .
Li B; Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Mar 22; Vol. 21 (1), pp. 213. Date of Electronic Publication: 2023 Mar 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Chimeric Antigen*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Lymphoma, B-Cell*
Humans ; Child ; Immunotherapy, Adoptive/adverse effects ; Immunotherapy, Adoptive/methods ; T-Lymphocytes ; Recurrence ; Antigens, CD19 ; Sialic Acid Binding Ig-like Lectin 2
Czasopismo naukowe
Tytuł:
The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia.
Autorzy:
Wang J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Sun K; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chen WM; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Li LD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Hao Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Xu N; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Mar; Vol. 64 (3), pp. 698-706. Date of Electronic Publication: 2023 Jan 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Adult ; Humans ; Prognosis ; Receptors, Cytokine/genetics ; Retrospective Studies ; Philadelphia Chromosome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies